FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine
WEBI am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on …
News Details - Moderna
WEBMar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Moderna Advances Multiple Vaccine Programs to Late-Stage …
WEBMar 27, 2024 · Moderna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
WEBSep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the …
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine
WEBSep 8, 2023 · I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved our supplemental Biologics License Application (sBLA) for Spikevax® (COVID-19 Vaccine, mRNA) for individuals 12 years of age and older, which helps protect against the most dominant variants as recommended by the June 2023 FDA VRBPAC.
FDA approves COVID shots from Moderna and Pfizer : Shots
WEBSep 11, 2023 · The vaccines from Moderna and Pfizer and its partner BioNTech were approved Monday for people 12 and older and under an emergency use authorization for children ages 6 months to 11 years old.
Moderna, Pfizer say updated Covid vaccines were effective against ...
WEBSep 6, 2023 · New Covid vaccines from Moderna and Pfizer produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, the companies said ...
The FDA just approved the new Covid vaccine: When to get it
WEBAug 22, 2024 · Pfizer, Moderna and Novavax are charging up to $150 per dose for a Covid vaccine, according to data from the Centers for Medicare and Medicaid Services.